Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population

Journal of Investigative Medicine

Volumn 62, Issue 6, 2014, Pages 868-874

  Sirmans, Susan M ^a   Parish, Roy C ^a,b   Blake, Sandra ^a   Wang, Xiaojun ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

Author keywords

Anxiety; Bipolar disorders; Cardiovascular risk factors; Depression; Eating disorders; Infertility; Obstructive sleep apnea; Polycystic ovary syndrome

Indexed keywords

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DYSLIPIDEMIA; DYSMETABOLIC SYNDROME; EATING DISORDER; FEMALE; GLUCOSE INTOLERANCE; HEALTH CARE COST; HEART FAILURE; HIRSUTISM; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INDIGENT; INFERTILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAID; METABOLIC SYNDROME X; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RACE; SLEEP DISORDERED BREATHING; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; ECONOMICS; HEALTH SURVEY; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POVERTY; PROCEDURES; RISK FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; LOUISIANA; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYCYSTIC OVARY SYNDROME; POPULATION SURVEILLANCE; POVERTY; RISK FACTORS; YOUNG ADULT;

EID: 84906544549     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.1097/01.JIM.0000446834.90599.5d     Document Type: Article

References (36)

1. Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562-2568.
2. Talbott EO, Zborowski JV, Rager JR, et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:5454-5461.
3. Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab. 2007;92:4609-4614.
4. Talbott EO, Zborowski JV, Rager J, et al. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? Vasc Health Risk Manag. 2008;4:453-462.
5. Guzick DS, Talbot EO, Sutton-Tyrrell K. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol. 1996;174:1224-1232.
6. Carmina E, Orio F, Palomba S, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119:356.
7. Vryonidou A, Papatheodorou A, Tavridou A, et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2740-2746.
8. Orio Jr F, Palomba S, Cascella T, et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004; 89(9):4588-4593.
9. Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141-146.
10. Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-169.
11. Sirmans SM, Weidman-Evans E, Everton V, et al. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications. Ann Pharmacother. 2012;46:403-418.
12. Dokras A. Mood and anxiety disorders in women with PCOS. Steroids. 2012;77:338-341.
13. Dokras A, Clifton S, Futterweit W, et al. Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2012;97(1):225-230.
14. Klipstein KG, Goldberg JF. Screening for bipolar disorder in women with polycystic ovary syndrome: a pilot study. J Affect Disord. 2006;91(2, 3):205-209.
15. McCluskey S, Evans C, Lacey JH, et al. Polycystic ovary syndrome and bulimia. Fertil Steril. 1991;55(2):287-291.
16. Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:1175-1180.
17. Vgontzas AN, Legre RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86:517-520.
18. Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078-3082.
19. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.
20. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544-551.
21. Mehrabian F, Khani B, Kelishadi R, et al. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynol Pol. 2011;62(3):238-242.
22. Tehrani FR, Simbar M, Tohidi M, et al. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol. 2011;9:39.
23. Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067-3073.
24. Alvarez-Blasco F, Botella-Carretero JI, San Millan JL, et al. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166:2081-2086.
25. Azziz R, Marin C, Hoq L, et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90:4650-4658.
26. Lo JC, Feigenbaum SL, Yand J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357-1363.
27. Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol. 1998;51:581-586.
28. Talbott EO, Zborowski JV, Boudreaux MY, et al. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(12):6061-6067.
29. Shaw LJ, Bairey Merz CN, Azziz R, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276-1284.
30. Hollinrake E, Abreu A, Maifeld M, et al. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87:1369-1376.
31. Dokras A, Clifton S, Futterweit W, et al. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol. 2011;117(1):145-152.
32. Jedel E, Gustafson D, Waern M, et al. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome. Psychoneuroendocrinology. 2011;36:1470-1479.
33. Rassi A, Veras AB, dos Reis M, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry. 2010;51:599-602.
34. Merikangas KR, Spence A, Kupfer DJ. Linkage studies of bipolar disorder: methodologic and analytic issues. Arch Gen Psychiatry. 1989;46:1137-1141.
35. Kerchner A, Lester W, Stuart SP, et al. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril. 2009;91:207-212.
36. American Diabetes Association. Standards of medical care in diabetesV2013. Diabetes Care. 2013;36(suppl 1):S11-S66.